The effect of Vimala massage on stress hormone levels in the saliva of premature babies

ISRCTN ISRCTN75126874
DOI https://doi.org/10.1186/ISRCTN75126874
Submission date
25/03/2022
Registration date
29/03/2022
Last edited
28/03/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
In neonatal intensive care units across the world, premature babies are exposed to a very stressful environment with high levels of noise, bright lights, pain, infections, invasive procedures, and a lack of maternal contact. Massage has been reported to be associated with decreased levels of stress, cortisol and with increased oxytocin levels. The aim of this study is to assess the impact of Vimala massage on salivary cortisol levels, clinical signs of stress and growth in premature babies admitted to a neonatal intensive care unit.

Who can participate?
Premature babies (28-36 weeks gestational age) admitted to a nursery unit

What does the study involve?
Participants are randomly allocated to receive 15-20 minutes of Vimala massage administered by their parents twice daily and usual care, or to receive usual care only. Salivary cortisol levels are measured on days 1 and 5. Heart rate, breathing rate, calorie intake, weight gain and growth are recorded daily.

What are the possible benefits and risks of participating?
The possible benefits of participating are lower cortisol levels and stability of clinical signs of stress. The risks of participating are possible discomfort from massage.

Where is the study run from?
High Specialty Medical Unit No 48, Mexican Institute of Social Security (Mexico)

When is the study starting and how long is it expected to run for?
March 2015 to February 2016

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dra Alma Patricia González
patipili999@hotmail.com

Contact information

Dr Alma Patricia Gonzalez
Principal Investigator

Av México e insurgentes s/N
col. Los paraísos
Leon
37296
Mexico

ORCiD logoORCID ID 0000-0002-3401-7519
Phone +52 (0)4771329126
Email patipili999@hotmail.com
Dr Gloria Patricia Sosa Bustamante
Scientific

Av México e insurgentes s/N
col. Los paraísos
Leon
37328
Mexico

ORCiD logoORCID ID 0000-0002-8460-4965
Phone +52 (0)477 393 14 26
Email patriciasb@hotmail.com

Study information

Study designSingle-center interventional blinded randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleSalivary cortisol in premature neonates treated with Vimala massage: a randomized controlled trial
Study objectivesVimala massage impacts the salivary cortisol levels, clinical signs of stress and growth in premature neonates admitted to a neonatal intensive care unit
Ethics approval(s)Approved 19/08/2015, Local Health Research Committee 1002 (México e Insurgentes Av. León Gto. México. +52 (0)477 7174800 ext 31804; investigaUMAE48@gmail.com), ref: R-2015-1002-29
Health condition(s) or problem(s) studiedPerinatal health
InterventionAfter consent, patients are randomized 1:1 to receive usual nursing care plus Vimala massage (intervention) or usual nursing care alone (control). In the intervention group, parents receive a 20-minute individual session with their child, where they are shown the massage techniques to use and given a printed booklet illustrating the different positions and movements. Parents are then asked to demonstrate the massage maneuvers and demonstrate proficiency in at least 80% of the massage components. The massage is performed by the parents under moderate pressure twice a day for 15-20 minutes on five consecutive days, at 12:00 and 18:00 under the supervision of one of the researchers.

A saliva sample is collected 1 hour before the first day of massage and after 5 days of massage, and at equivalent time points in control infants. Samples are collected between 11:00 and 12:00 and newborns must fast for at least 1 hour before sampling. To stimulate saliva production, two drops of 30% glucose solution are placed on the infants' tongue before the sample was obtained. After oral inspection to ensure there is no milk contamination, a plastic Pasteur pipette is placed inside the cheek to collect the sample. The sample is immediately transferred to plastic test tubes and transported to the laboratory where it is stored at -20°C. Cortisol is measured using the DRG Salivary Cortisol by ELISA test (DRG Instruments GmbH, Marburg, Germany). The test has detection limits of 0.0537 to 8 micrograms per deciliter with an inter-assay variation of 7.47% and an intra-assay variation of 2.65%.
Intervention typeBehavioural
Primary outcome measureSalivary cortisol measured using the DRG Salivary Cortisol by ELISA test (DRG Instruments GmbH, Marburg, Germany) 1 hour before the first day of massage and after 5 days of massage, and at equivalent timepoints in control infants
Secondary outcome measures1. Heart rate, respiratory rate, and oxygen saturation measured with a Choice brand model MMED 600DP vital signs monitor with saturation sensor in the right hand for five consecutive days between 7:00 and 8:00 am
2. Weight measured with a digital scale Se GmbH & Co. Kg model 374 1321009 (Hamburg, Germany) for five consecutive days at 8:00 am
3. Length measured with a non-elastic anthropometric tape, Seca 201® for five consecutive days at 8:00 am
Overall study start date01/03/2015
Completion date28/02/2016

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants70
Total final enrolment72
Key inclusion criteria1. Premature neonates born by caesarean section or vaginal delivery
2. 28-36 weeks of gestational age (Ballard scale)
3. Admitted to the nursery unit
4. Fed by mouth
5. Hemodynamically stable
6. Required no respiratory support
7. Unremarkable physical examination
8. A parent (mother or father) had to be available and willing to provide massage to the neonate
Key exclusion criteriaPatients with active infections
Date of first enrolment30/09/2015
Date of final enrolment30/12/2015

Locations

Countries of recruitment

  • Mexico

Study participating centre

Neonatal unit of the Gynecology and Pediatric Hospital Number 48 of the Mexican Institute of Social Security
Av México e insurgentes s/N
col. Los paraísos
León Guanajuato
37328
Mexico

Sponsor information

Gynecology and Pediatric Hospital Number 48 of the Mexican Institute of Social Security
Hospital/treatment centre

Av México e insurgentes s/N
col. Los paraísos
Leon
37328
Mexico

Phone +52 (0)477 7174800 ext 31804
Email investigaumae48@gmail.com

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date30/05/2022
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available at a later date

Editorial Notes

28/03/2022: Trial's existence confirmed by the Local Health Research Committee 1002.